Effects of empagliflozin on hyperuricaemia and heart failureEmpagliflozin, a sodium-glucose cotransporter-2 inhibitor, induces a rapid and sustained reduction in serum uric acid levels and decreases the risk of cardiovascular death or hospitalization for heart failure. Should considering pollution have a place in prescribing practices? An eco-formulary has been developed in Scotland. Many seniors have a vitamin B12 deficiency: study Researchers suggest simple—but specific—dietary changes would help. Pediatric cell-based vaccine as good as egg-based vaccine for influenza, clinical trial An important advancement in pediatric influenza vaccines. 2022 tax forms in Ontario, Nunavut to offer access to organ donor information The federal government has announced the two jurisdictions have agreed to participate in the service being offered by the Canada Revenue Agency. Electrolyte abnormalities often an early sign of eating disorders: study A large study published in JAMA Network Open found that many patients with unexplained electrolyte abnormalities would go on to be diagnosed with eating disorders. Low-dose statins better at lowering bad cholesterol than supplements But a garlic dietary supplement slightly increased LDL. Pfizer booster spurs immune response to new omicron subtypes With relatives of BA.5 now on the rise, a question is how the new boosters will hold up. Why South Asians are at increased risk for diabetes: A complex interplay of genetics, diet and history In Canada, 14.4% of South Asians have Type 2 diabetes, the highest prevalence of any other ethnic group in the country. TNFα-inhibitor biologics for rheumatic disease linked to the development of MS Study examines risk of multiple sclerosis among users of antitumour necrosis factor alpha biologics in four Canadian provinces First Previous 146 147 148 149 150 Next Last
